Working together, we can create successful new generics partnerships. Combining innovative business models with collaborative process development helps to strengthen our customers’ products, while reducing your risk. Our APIs and life cycle management offering is supported by our network of development and commercial manufacturing facilities in Europe, North America and Asia, to meet your global product requirements.

We offer an extensive range of generic APIs and invaluable expertise for developing many more. Risk reduction is ensured through partnering with us and our smart technologies and complex chemistries can help to strengthen IP to ensure a competitive position in the market.

 

Download API and Controlled Substance Product Guide
 

API products

Filter by:

Apomorphine HCl

CAS number: 41372-20-7
See more

Atropine Sulfate

CAS number: 5908-99-6
See more

Auranofin

CAS number: 34031-32-8
See more

Baricitinib

CAS number: 1187594-09-7
See more

Carboplatin

CAS number: 41575-94-4
See more

Carmustine

CAS number: 154-93-8
See more

Cisplatin

CAS number: 15663-27-1
See more

Decitabine

CAS number: 2353-33-5
See more

Dofetilide

CAS number: 115256-11-6
See more

Edrophonium Chloride

CAS number: 116-38-1
See more

Isoproterenol HCl

CAS number: 51-30-9
See more

Lenalidomide

CAS number: 191732-72-6
See more

Lurasidone HCl

CAS number: 367514-88-3
See more

Miglustat

CAS number: 72599-27-0
See more

Naloxone HCl

CAS number: 51481-60-8
See more

Nintedanib

CAS number: 656247-18-6
See more

Pirfenidone

CAS number: 53179-13-8
See more

Pomalidomide

CAS number: 19171-19-8
See more

Selinexor

CAS number: 1393477-72-9
See more

Venetoclax

CAS number: 1257044-40-8
See more

Vismodegib

CAS number: 879085-55-9
See more

Voxelotor

CAS number: 1446321-46-5
See more

Controlled substances

Learn more

Featured insights from our experts

Read more

Ultra-pure synthetic cannabidiol (CBD)

We’re utilising our scientific and manufacturing expertise to develop and commercialise ultra-pure synthetic…

Early form screening strategies to accelerate candidate selection

Failure to select a successful candidate can be expensive in terms of both time and money.

Crystallization process development

Providing a first-choice opportunity—adopting crystallization development at an early stage.

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us